Inhibition of Lactobacillus casei thymidylate synthetase by 5-substituted 2'-deoxyuridylates. Preliminary quantitative structure-activity relationship

Journal of Medicinal Chemistry
1977.0

Abstract

The binding of a series of 5-substituted 2'-deoxyuridylates to Lactobacillus casei thymidylate synthetase has been determined by their inhibition of thymidylate formation and of dehalogenation of 5-bromo-2'-deoxyuridylate. As inhibitors of thymidylate formation, the apparent dissociation constants of this series span over three orders of magnitude, and quantitative structure-activity relationships (QSAR) could be established. The most important parameters are the electronic σ- constant and the polar ς constant which indicates that electron withdrawal from the uracil heterocycle increases affinity for the enzyme. The effect cannot be solely ascribed to changes in acidity of the 3-NH and must involve other electronic perturbations of the uracil moiety. The steric parameter, MR, has a negative coefficient indicating that in the series tested the bulkier 5-substituents are detrimental to binding. Hydrophobic effects do not appear to be important in the differential binding of the 5-substituted analogues examined. The same series of analogues shows similar affinities for the enzyme in the absence of the cofactor, as determined by their inhibition of dehalogenation of 5-bromo-2'-deoxyuridylate in the absence of the cofactor, 5,10-methylenetetrahydrofolate. Although QSAR could not be established using this assay, it is clear that the binding regions of 5-substituted 2'-deoxyuridylates are dramatically different in the enzyme and enzyme-cofactor complex. Thymidylate synthetase catalyzes the conversion of 2'-deoxyuridylate (dUMP) to thymidylate (dTMP), with concomitant transfer and reduction of the one carbon unit of 5,10-methylenetetrahydrofolate (CH2-H4folate). Because this enzyme represents the sole de novo pathway for dTMP synthesis, it has been a popular target for design of inhibitors with potential chemotherapeutic applications. Thus far, the most useful inhibitors of thymidylate synthetase have been 5-substituted 2'-deoxyurid ylates. The nature of the 5-substituents has dramatic effects on the affinity for this enzyme, and such analogues seemed ideal candidates for construction of quantitative structure-activity relationships. In this report, we describe equations which correlate the inhibition of Lactobacillus casei thymidylate synthetase by nine 5-substituted 2' deoxyuridylates. The results permit assessment of the features of the 5-substituent which are important for binding and provide a basis for rational development of more potent inhibitors of this enzyme.

Knowledge Graph

Similar Paper

Inhibition of Lactobacillus casei thymidylate synthetase by 5-substituted 2'-deoxyuridylates. Preliminary quantitative structure-activity relationship
Journal of Medicinal Chemistry 1977.0
Thymidylate synthetase inhibitors. Synthesis of N-substituted 5-aminomethyl-2'-deoxyuridine 5'-phosphates
Journal of Medicinal Chemistry 1977.0
5-p-Benzoquinonyl-2'-deoxyuridine 5'-phosphate: a possible mechanism-based inhibitor of thymidylate synthetase
Journal of Medicinal Chemistry 1983.0
A potent multisubstrate analog inhibitor of human thymidylate synthetase
Journal of Medicinal Chemistry 1984.0
Inhibition of thymidylate synthetase by 5-alkynyl-2'-deoxyuridylates
Journal of Medicinal Chemistry 1981.0
Thymidine phosphorylase. Substrate specificity for 5-substituted 2'-deoxyuridines
Journal of Medicinal Chemistry 1980.0
Understanding the Binding of 5-Substituted 2‘-Deoxyuridine Substrates to Thymidine Kinase of Herpes Simplex Virus Type-1
Journal of Medicinal Chemistry 1996.0
Synthesis of modified pyrimidine bases and positive impact of chemically reactive substituents on their in vitro antiproliferative activity
European Journal of Medicinal Chemistry 2009.0
Quantitative Structure−Activity Relationships of 2,4-Diamino-5-(2-X-benzyl)pyrimidines versus Bacterial and Avian Dihydrofolate Reductase
Journal of Medicinal Chemistry 1998.0
Interaction of 1-(5-phospho-.beta.-D-arabinofuranosyl)-5-substituted-uracils with thymidylate synthetase: mechanism-based inhibition by 1-(5-phospho-.beta.-D-arabinofurosyl)-5-fluorouracil
Journal of Medicinal Chemistry 1981.0